The multinational pharma company will access Tempus’ AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
Pfizer, Tempus collaborate on cancer drug development
The multinational pharma company will access Tempus’ AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
